HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Inhibitory effects of a novel aromatase inhibitor, YM511, on growth of endometrial explants and insulin-like growth factor-I gene expression in rats with experimental endometriosis.

Abstract
Estrogen deprivation therapy effectively prevents progress of endometriosis but the precise mechanism by which estrogen stimulates growth of endometriotic implants is still unknown. We examined effects of hypoestrogenic state induced by ovariectomy, gonadotropin-releasing hormone agonist (leuprolide) or aromatase inhibitor (YM511), on growth of experimental endometrial explant, a section of endometrium transplanted under the renal capsule, in rats. Ovariectomy gradually reduced the volume of endometrial explants for 21 days. YM511 (0.1 mg/kg) and leuprolide (1 mg/rat) completely reduced volume of endometrial explants but they differed widely in the onset of inhibitory action. YM511 prevented growth of explants on day 4 but leuprolide had no inhibitory effect until day 15. YM511 dose-dependently reduced volume of endometrial explants and its minimum effective dose was 0.04 mg/kg. Insulin-like growth factor-I (IGF-I) mRNA expression in endometrial explant and uterus was examined on day 4. YM511 decreased IGF-I expression in endometrial explant and uterus by 58% and 48%, respectively. Reductions of the extent of IGF-I expression by YM511 and ovariectomy were comparable. A significant correlation between the volume and IGF-I mRNA expression in endometrial explant suggests that local expression of this gene may play an important role in stimulating growth of endometrial explants.
AuthorsM Kudoh, Y Susaki, Y Ideyama, T Nanya, M Mori, H Shikama
JournalThe Journal of steroid biochemistry and molecular biology (J Steroid Biochem Mol Biol) 1997 Sep-Oct Vol. 63 Issue 1-3 Pg. 75-80 ISSN: 0960-0760 [Print] ENGLAND
PMID9449208 (Publication Type: Journal Article)
Chemical References
  • Antineoplastic Agents, Hormonal
  • Aromatase Inhibitors
  • Enzyme Inhibitors
  • RNA, Messenger
  • Triazoles
  • YM 511
  • Insulin-Like Growth Factor I
  • Leuprolide
Topics
  • Animals
  • Antineoplastic Agents, Hormonal (pharmacology)
  • Aromatase Inhibitors
  • Endometriosis (genetics, prevention & control)
  • Endometrium (drug effects, growth & development, transplantation)
  • Enzyme Inhibitors (pharmacology)
  • Female
  • Gene Expression (drug effects)
  • Insulin-Like Growth Factor I (drug effects, genetics)
  • Leuprolide (pharmacology)
  • Ovariectomy
  • RNA, Messenger (metabolism)
  • Rats
  • Rats, Sprague-Dawley
  • Triazoles (pharmacology)
  • Uterus (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: